News | News By Subject | News by Disease News By Date | Search News

Brain cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
The 7 Worst Clinical Disasters of 2016     12/27/2016
ZIOPHARM Abandons $50 Million Stock Offering After Clinical Trial Deaths     7/18/2016
NW Bio (NWBO) Temporarily Halts Patient Screening for DCVax-L Brain Cancer Study     8/24/2015
Progenics Pharmaceuticals, Inc. (PGNX) Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma And Paraganglioma     7/28/2015
ASCO15 EXCLUSIVE: Experimental Brain Cancer Drugs Heads to Phase II/III Trial This Year: DelMar Pharmaceuticals CEO     6/3/2015
ASCO15: BioSpace (DHX)'s Roundup of What You May Have Missed at ASCO So Far     6/1/2015
ASCO15: Hope Rises As Celldex (CLDX)'s Brain Cancer Vaccine Helps Patients Live Longer     6/1/2015
Celldex (CLDX)'s Brain Cancer Drug Rintega Will Take Center Stage at ASCO     5/29/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
EXCLUSIVE: DelMar Pharmaceuticals CEO Outlines 2015 Plans, Looks to Clinical Cancer Trials     3/2/2015
EXCLUSIVE: Science "Finally Catching Up" With GBM Tumors, Says DelMar Pharmaceuticals CEO     2/27/2015
Celldex (CLDX)'s Rindopepimut Deemed a Breakthrough By the FDA     2/24/2015
CytRx Corporation (CYTR)'s Brain Cancer Drug Shows Promise in Mid-Stage Study     1/6/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014

News from Around the Web
'Sticky' Particles Promise More Precise Drug Delivery For Brain Cancer, Yale Study     5/22/2017
Investors Ready for Brain Cancer Biotech Tocagen's Upcoming IPO This Wednesday     4/11/2017
Stock Tanks As NW Bio (NWBO) CTO Pleads Ignorance On Why Study Was Placed On Clinical Hold     4/5/2017
City of Hope Researchers Achieve Remission Using CAR-T Cell Therapy For Aggressive Brain Tumors     12/29/2016
A New Approach For A Deadly Brain Cancer, MD Anderson Cancer Center Study     11/9/2016
Carthera SonoCloud Opens Up Blood-Brain Barrier And New Potential For Brain Cancer Treatment     6/22/2016
Brain Tumor Risk Linked To The Wealthier, Better-Educated, Study Published In BMJ     6/21/2016
Immune Genes Tied To Common, Deadly Brain Cancer Identified, First Hospital Of China Medical University Researchers Reveal     5/27/2016
Loss For Words Can Be A Rare Brain Disorder, Not Alzheimer's, Johns Hopkins University Study     2/15/2016
Device Claims To Suppress Brain-Cancer Cell Growth     2/1/2016
"Smart Fat Cells" Cross Blood-Brain Barrier To Catch Early Brain Tumors, Penn State University Study     12/29/2015
Electromagnetic Waves May Help Fight Deadly Brain Cancer, University Hospital Zurich     12/16/2015
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer, EPFL Study     9/25/2015
This Illegal Drug Could Be The Answer To Fighting Brain Cancer     12/15/2014
Longer Telomeres Linked to Risk of Brain Cancer, University of California, San Francisco (UCSF) Study     6/9/2014

Press Releases
Diffusion Pharma Achieves Drug Production Milestone For Planned Phase III Clinical Trial In Inoperable GBM Brain Cancer     7/20/2017
IsoRay (ISR) Shows Off Another '100%' Study     6/21/2017
Cascadian Therapeutics (ONTY)’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation From FDA For Treatment Of Breast Cancer Patients With Brain Metastases     6/8/2017
2X Oncology Obtains Investigational New Drug Application For 2X-111 Glutathione Enhanced PEGylated Liposomal Doxorubicin     6/8/2017
MagForce AG Co-Sponsors Brain Cancer Patient Event Of University Hospital Münster Held On Occasion Of The 2017 World Brain Tumor Day     6/8/2017
Medtronic (MDT) SureTune3 Receives Health Canada Licence For Deep Brain Stimulation Therapy     6/6/2017
Orbus Therapeutics Announces ASCO Study Design Presentation Of Pivotal Clinical Trial In Patients With Late-Stage Brain Cancer     6/5/2017
FDA Allows NuvOx Pharma To Run A Phase II Clinical Trial In Brain Cancer     4/13/2017
BlackThorn Therapeutics Announces Results Of Preclinical Study Of BTRX-335140, Demonstrating Therapeutic Potential In Modulating Brain Circuits Commonly Dysregulated In Neurobehavioral Disorders     4/6/2017
Creative Medical Technology Files Patent On Reducing Radiation Toxicity Using AmnioStem Universal Donor Stem Cell Product     4/5/2017
NICO Corporation Announces CE Mark For BrainPath Non-Disruptive Cranial Access Technology     4/3/2017
Ignyta (RXDX) Announces Peer-Reviewed Publication Of Activity Of A TRK Inhibitor In A Primary Brain Tumor: Successful Treatment Of Glioneuronal Tumor With Pan-TRK, CNS-Active Inhibitor Entrectinib Published In Precision Oncology     3/30/2017
St. Jude Children's Research Hospital Release: Caution Needed For Drugs In Development For Most Common Malignant Pediatric Brain Tumor     3/22/2017
Tempus Teams With Major Academic Medical Center To Advance Treatment Options For Patients Diagnosed With Aggressive Brain Cancer     3/2/2017
Tocagen Achieves Key Development Milestone For Lead Product: Phase II Randomized Trial In Patients With Recurrent Brain Cancer Fully Enrolled     2/23/2017